Executive Summary

Dexcom, which makes glucose monitoring equipment and technology, is betting that it can dramatically expand its total addressable market for people with diabetes with a big assist from generative artificial intelligence (GenAI).

Get Access to This Premium Content
Already a member? Login to Access
Premium Content

Premium content. Log in to your account here. If you do not have a premium membership login, become a member of the Constellation Executive Network or Research Unlimited account or Insights. Please contact [email protected] to ask about your access options or click the price below to purchase this report individually.

Purchase Options
Become a Member Executive Network
Become a Member Research Unlimited
Become a Member Insights
Purchase $2,035 Single Report Purchase